Antichagasic profile of a Series of Mannich Base‐Type Derivatives: Design, Synthesis, in vitro Evaluation, and Computational Studies Involving Iron Superoxide Dismutase-Reference-Cited by-同舟云学术

Antichagasic profile of a Series of Mannich Base‐Type Derivatives: Design, Synthesis, in vitro Evaluation, and Computational Studies Involving Iron Superoxide Dismutase

Published:2019-07-22 Issue:27 Volume:4 Page:8112-8121
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Paucar Rocío¹,Martín‐Escolano Rubén²,Moreno‐Viguri Elsa¹,Cirauqui Nuria³,Marín Clotilde²,Sánchez‐Moreno Manuel²,Pérez‐Silanes Silvia¹^ORCID

Affiliation:

1. Universidad de NavarraDepartment of Pharmaceutical Technology and ChemistryInstituto de Salud Tropical Pamplona 31008 Spain

2. Department of ParasitologyInstituto de Investigación Biosanitaria (ibs. Granada)Hospitales Universitarios de Granada/University of Granada, Severo Ochoa s/n, E-18071, Granada Spain

3. Department of Pharmaceutical SciencesFederal University of Rio de Janeiro Rio de Janeiro 21949–900 Brazil

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.201901108

Reference44 articles.

1. Accessed: 13 March 2019 “Chagas disease (American trypanosomiasis)” to be found under http://www.who.int/en/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis) 2018.

2. Accessed: 27 November 2018 “Investing to overcome the global impact of neglected tropical diseases: third WHO report on neglected tropical diseases Chagas disease” to be found under https://www.who.int/neglected_diseases/9789241564861/en/ 2015.

3. Current drug therapy and pharmaceutical challenges for Chagas disease

4. Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease

5. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets;Expert Opinion on Therapeutic Targets;2023-10-03

2. 2,3-Diketopiperazine as potential scaffold to develop new anti-Chagasic agents;Medicinal Chemistry Research;2022-12-16

3. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease;Bioorganic & Medicinal Chemistry;2022-03